Cargando…
Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19
Since the first case reports in Wuhan, China, the SARS-CoV-2 has caused a pandemic and took lives of > 8,35,000 people globally. This single-stranded RNA virus uses Angiotensin-converting enzyme 2 (ACE2) as a receptor for entry into the host cell. Overexpression of ACE2 is mainly observed in hype...
Autores principales: | Kumar, Pravindra, Sah, Ashok Kumar, Tripathi, Greesham, Kashyap, Anjali, Tripathi, Avantika, Rao, Rashmi, Mishra, Prabhu C., Mallick, Koustav, Husain, Amjad, Kashyap, Manoj Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539757/ https://www.ncbi.nlm.nih.gov/pubmed/33029696 http://dx.doi.org/10.1007/s11010-020-03924-2 |
Ejemplares similares
-
Tumor reversion: a dream or a reality
por: Tripathi, Avantika, et al.
Publicado: (2021) -
Aging and diabetes drive the COVID-19 forwards; unveiling nature and existing therapies for the treatment
por: Chawla, Udeep, et al.
Publicado: (2021) -
Drug-Repurposing
Approach To Combat Staphylococcus
aureus: Biomolecular and Binding Interaction Study
por: Singh, Vishakha, et al.
Publicado: (2022) -
Structural characterization and in-silico analysis of Momordica charantia 7S globulin for stability and ACE inhibition
por: Kesari, Pooja, et al.
Publicado: (2020) -
Repurposing of gastric cancer drugs against COVID-19
por: Sonkar, Charu, et al.
Publicado: (2021)